One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Health priorities for Kamala Harris
doi : 10.1016/S0140-6736(24)01687-8
Volume 404, Issue 10453, 17–23 August 2024, Page 629
Protein provision during critical illness
Christian Stoppe a b, Wolfgang H Hartl c
Extending the boundaries of organ preservation: hope for heart transplantation
Michelle MÂ Kittleson
The ongoing fight for population oral health
Carol C Guarnizo-Herreño a, Roger Keller Celeste b, Marco A Peres c
The HIV response beyond 2030: preparing for decades of sustained HIV epidemic control in eastern and southern Africa
The Post-2030 HIV Response Working Group*
Low tar cigarette marketing driving a boom in sales in China
Jason McLure, Jude Chan
Mandy Cohen: public health advocate and Director of the US CDC
Susan Jaffe
Solutions to the medical practice of silencing
Annabel Sowemimo
A global ethics charter to protect healthy volunteers
Jill A Fisher a, François Bompart b c, Lorenzo Montrasio d, Shadreck Mwale e, Chun Keat Chew f, Sucheta B Kurundkar g, Yves Donazzolo h, François Hirsch i
Addressing the deficiencies in stroke care in Pakistan
Saad Javed a, Dua Abbas Zaidi a, Eesha Yaqoob a
Validity of the diagnostic criteria for Parkinson's disease
Yue He a b, Jian-Gang Wang a, Chang-Qing Gao c
Validity of the diagnostic criteria for Parkinson's disease – Authors' reply
Connie Marras a, Yoav Ben-Shlomo b, Sirwan K L Darweesh c, Jorge Llibre-Guerra d, Caroline Tanner e
Limitations of non-invasive ultrasound therapy for valve stenosis
Dongbo Ou a, Caiyou Hu a, Shian Huang b
Limitations of non-invasive ultrasound therapy for valve stenosis
Kazuo Komamura a, Hiroshi Miyake a, Koichi Kobayashi a, Mitsunori Iwase a
Limitations of non-invasive ultrasound therapy for valve stenosis – Authors' reply
Emmanuel Messas a, Alexander Ijsselmuiden b, Danijela Trifunović-Zamaklar c
Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial
Hyunjae Shin a b, Jeong-Hoon Lee a
Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial
Matteo Donadon a b, Marcello Di Martino a b, Cristina Rigamonti c d
Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial
Zhu Chen a, Xiang Lan a, Chengyou Du a, Heng Xiao a
Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial
Sweta Rose a, Muhammad Uwais Ashraf a, Madhumita Premkumar a
Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial – Authors' reply
Pierce K H Chow a b, Stephen P Hack c, Jessica H Spahn c, Adam C Yopp d
Effect of high versus standard protein provision on functional recovery in people with critical illness (PRECISe): an investigator-initiated, double-blinded, multicentre, parallel-group, randomised controlled trial in Belgium and the Netherlands
Julia L M Bels MD a d, Steven Thiessen MD g i j, Rob J J van Gassel MD a d, Albertus Beishuizen MD k, Ashley De Bie Dekker MD l m, Vincent Fraipont MD n, Stoffel Lamote MD o, Prof Didier Ledoux MD p, Clarissa Scheeren MD q, Prof Elisabeth De Waele MD r s, Prof Arthur R H van Zanten MD t u, Laura Bormans-Russell RN q, Bas C T van Bussel MD a e f, Marlies M J Dictus MSc h, Tom Fivez MD g, Ingeborg Harks BSc l, Prof Iwan C C van der Horst MD a e, Prof Joop Jonckheer MD r, Hugues Marechal MD n, Prof Paul B Massion MD p…Adam Deane
Hypothermic oxygenated perfusion of the donor heart in heart transplantation: the short-term outcome from a randomised, controlled, open-label, multicentre clinical trial
Prof Filip Rega PhD a , Prof Guillaume Lebreton PhD b , Marylou Para MD c , Prof Sebastian Michel PhD d e , Prof René Schramm PhD f , Emmanuelle Begot MD b , Katrien Vandendriessche MD a , Christine Kamla MD d e , Prof Gino Gerosa MD g , Marius Berman MD h , Prof Udo Boeken PhD i , Prof Steven Clark PhD j , Aaron Ranasinghe MD k , Fabio Ius PhD l , Alberta Forteza PhD m , Aldina Pivodic PhD n , Felix Hennig MD o p q , Sabina Guenther MD f , Andreas Zuckermann PhD r , Prof Christoph Knosalla PhD o p q … Emilio Osorio aq
Efficacy and safety of emodepside compared with albendazole in adolescents and adults with hookworm infection in Pemba Island, Tanzania: a double-blind, superiority, phase 2b, randomised controlled trial
Lyndsay Taylor MSc a b, Ahmada Ali Ahmada c, Msanif Said Ali c, Said Mohammed Ali MSc c, Jan Hattendorf PhD a b, Ibrahim Said Mohammed MD c, Prof Jennifer Keiser PhD a b
Fibrofatty involution of rhabdomyomas: a longitudinal series of cardiac MRI studies in a patient with possible tuberous sclerosis complex
Joana Ferreira MD a b, Paula Poveda Velazquez MD a, Marina Zaromytidou PhD a, Giulia Montrasio MD a, Prof Saidi Mohiddin PhD a, Neha Sekhri PhD a
Chronic lymphocytic leukaemia
Prof Nitin Jain MD a, Prof William G Wierda MD PhD a, Prof Susan O'Brien MD b
Long COVID: a clinical update
Prof Trisha Greenhalgh MD a, Prof Manoj Sivan MD b, Alice Perlowski MD c, Prof Janko Ž Nikolich MD d e
